19, n o 2, 18791894 (ISSN 2251-6581, PMID 33520867, PMCID 7843735, DOI 10.1007/s40200-020-00627-9, lire en ligne, consult le Sinha R., Cross A.J., Graubard B.I., Leitzmann M.F
December 2022
Learn more Semaglutide is a GLP-1 (glucagon-like-peptide-1) receptor agonist and is FDA approved for weight loss
CoQ10 has the strongest clinical evidence of any fertility supplement studied to date
The authors concluded: Further research is needed to determine if there is a true cause and effect relationship in the association identified in this investigation and to understand the trade-offs between the benefits and risks of GLP-1 RAs. Also in June, the European Medicines Agency safety committee warned that semaglutide (active substance in Ozempic, Rybelsus and Wegovy) may cause the NAION optic neuropathy described earlier in this article